YARTEMLEA Trademark

Trademark Overview


On Thursday, May 7, 2020, a trademark application was filed for YARTEMLEA with the United States Patent and Trademark Office. The USPTO has given the YARTEMLEA trademark a serial number of 88906252. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Omeros Corporation. The YARTEMLEA trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods

General Information


Serial Number88906252
Word MarkYARTEMLEA
Filing DateThursday, May 7, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Description of MarkThe mark consists of "YARTEMLEA" in all capital letters. Three horizontally stacked waving lines, the top two of which are three times longer than the lowest line, are positioned above the last two letters of "YARTEMLEA" with the top two lines extending to the right of the word. The letters "YARTEM" and the two top waving lines are purple and the letters "LEA" and the lowest waving line are gold.
Goods and ServicesBiological preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; preparations for diagnostic purposes are specifically excluded from all of the foregoing goods
Indication of Colors claimedThe color(s) purple and gold is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Monday, May 11, 2020NEW APPLICATION ENTERED
Wednesday, May 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 21, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, June 13, 2020ASSIGNED TO EXAMINER
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021SOU EXTENSION 1 FILED
Tuesday, February 16, 2021SOU EXTENSION 1 GRANTED
Thursday, February 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 20, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 20, 2021SOU EXTENSION 2 FILED
Friday, August 20, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 13, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 28, 2022SOU EXTENSION 3 FILED
Monday, February 28, 2022SOU EXTENSION 3 GRANTED
Wednesday, March 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 27, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 27, 2022SOU EXTENSION 4 FILED
Saturday, August 27, 2022SOU EXTENSION 4 GRANTED
Friday, September 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2022TEAS PETITION TO DIRECTOR RECEIVED
Wednesday, November 9, 2022ASSIGNED TO PETITION STAFF
Wednesday, November 9, 2022PETITION TO DIRECTOR GRANTED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023SOU EXTENSION 5 FILED
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 3, 2023SOU EXTENSION 5 GRANTED
Saturday, March 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED